A NOVA special featured Rhiju Das and the OpenVaccine project, in which gamers help scientists find an RNA molecule configuration for a COVID-19 vaccine.
Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors.
The Stanford Clinical Virology Laboratory is ramping up capacity for its coronavirus diagnostic test, which can deliver results in 24 hours.
Scientists found a sneaky way to stop cold viruses from replicating in mammalian cells by disabling a protein not in the virus but in the cells they infect.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
The conclusion of this series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics really improve health.
In a recent Stanford podcast, food allergy expert Kari Nadeau explains the latest research on predicting, preventing and treating allergies.
Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.
Selectively subduing a set of cells that migrate to the brain after a stroke occurs could meaningfully treat the stroke even days later.
Postdoctoral scholar Progga Sen reflects on her love of flowers and talks with physician Chitra Dinakar to learn more about the allergies they can cause.
In this In the Spotlight, Rebecca Saenz, a recent allergy and immunology fellow, describes her evolution as a physician/scientist and entrepreneur.
A method that broadens the pool of potential donors for stem cell transplants recently saved two young brothers from a severe genetic disease.
Third-year medical student Neil Rens explains why he chooses to advocate for stricter vaccination requirements in California.
Osteoarthritis has traditionally been thought to be an inevitable result of wear and tear. But it's now clear the immune system is playing a leading role.
Stanford researchers have developed a technique to encourage the immune system to target a section of the flu virus that is conserved year to year.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
